Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Stephanie Trexler, PharmD, BCOP

Articles by Stephanie Trexler, PharmD, BCOP

Use of Lutetium Lu-177 Vipivotide Tetraxetan to Treat Metastatic Castration-Resistant Prostate Cancer

ByStephanie Trexler, PharmD, BCOP

October 17th 2022

The FDA-approved, targeted radiopharmaceutical agent can contribute to a patient’s cumulative radiation exposure.

Latest Updated Articles

Use of Lutetium Lu-177 Vipivotide Tetraxetan to Treat Metastatic Castration-Resistant Prostate Cancer
Published: October 17th 2022 | Updated:

Trending on Pharmacy Times

December 2025 Product Updates

FDA Approves First Oral GLP-1 for Weight Management

A Healthy Gut Could Improve Mental Health

Reimagining Pharmacy: A Call to Action for Pharmacy Professionals

Lowering Blood Glucose in Prediabetes May Prevent Heart Attacks and Heart Failure